Czechia· CZ-0193815
RYZODEG
A insulin degludec und insulin aspart product containing insulin degludec + insulin aspart, registered in Czechia by Novo Nordisk A/S, Bagsvaerd. The same ATC class is registered in 9 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Insulin degludec und insulin aspart is registered in 9 of 19 countries.
Countries holding a registration under ATC A10AD06 (insulin degludec und insulin aspart), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 6 of them publish a price we can compare per daily dose
Insulin degludec und insulin aspart · ATC A10AD06
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- INSULIN DEGLUDEC + INSULIN ASPART
- Manufacturer
- Novo Nordisk A/S, Bagsvaerd
- Country
- Czechia (CZ)
- ATC code
- A10AD06
- ATC class
- Insulin degludec und Insulin aspart
- Defined daily dose
- 40 E, P
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl01938155X3ML ICZK 1723.12
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Insulin degludec und insulin aspart in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenRyzodeg FlexPen 100 enheter/ml Injektionsvätska, lösning i förfylld injektionspennaNovo Nordisk A/S
- FinlandRyzodeg FlexPenNovo Nordisk A/S
- IcelandRyzodegNovo Nordisk A/S*
- SwitzerlandRyzodeg FlexTouch , InjektionslösungNovo Nordisk Pharma AG
- NetherlandsRyzodeg 100 eenheden/ml oplossing voor injectie in patroonNovo Nordisk A.S.
- PolandRyzodegNovo Nordisk A/S
- IrelandRyzodeg 100 units/mL solution for injectionNovo Nordisk A/S
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Ryzodeg Flexpen, Ryzodeg Flextouch
- Norway · Ryzodeg Flexpen, Ryzodeg Flextouch
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4309d372-668b-4385-b7a6-62e3ccef25d9 GET /v1/drugs/4309d372-668b-4385-b7a6-62e3ccef25d9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SOL PEP",
"source": "sukl",
"strength": "100U/ML",
"pack_size": "5X3ML I",
"substance": "INSULIN DEGLUDEC + INSULIN ASPART",
"cz_kod_sukl": "0193815",
"product_type": "BT",
"substance_codes": "18626,15384",
"registration_state": "R",
"registration_number": "EU/1/12/806/004"
}See everything about insulin degludec und insulin aspart.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.